Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes

Gaurav Bharadwaj, Viet Nhan, Shan Chao Yang, Xiaocen Li, Anand Narayanan, Ana Carolina MacArenco, Yu Shi, Darrion Yang, Letícia Salvador Vieira, Wenwu Xiao, Yuanpei Li, Kit Lam

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aim: To structurally modify our existing cholic acid (CA)-based telodendrimer (TD; PEG5K-CA8) for effective micellar nanoencapsulation and delivery of the US FDA-approved members of taxane family. Materials & methods: Generation of hybrid TDs was achieved by replacing four of the eight CAs with biocompatible organic moieties using solution-phase peptide synthesis. Drug loading was done using the standard evaporation method. Results: Hybrid TDs can generate micelles with narrow size distributions, low critical micelle concentration values (1-6 μM), better hematocompatibility and lack of in vitro cytotoxicity. Conclusion: Along with PEG5K-CA8, CA-based hybrid nanoplatform is the first of its kind that can stably encapsulate all three FDA-approved taxanes with nearly 100% efficiency up to 20% (w/w) loading.

Original languageEnglish (US)
Pages (from-to)1153-1164
Number of pages12
JournalNanomedicine
Volume12
Issue number10
DOIs
StatePublished - May 1 2017

Fingerprint

Cholic Acid
Taxoids
Micelles
Acids
Critical micelle concentration
acid
Cytotoxicity
Peptides
Evaporation
drug
peptide
efficiency
lack
evaporation
Pharmaceutical Preparations
Values
method
taxane

Keywords

  • cabazitaxel
  • cholic acid
  • docetaxel
  • drug delivery
  • micelle
  • nanoparticle
  • paclitaxel
  • taxane
  • telodendrimer

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Bioengineering
  • Biomedical Engineering
  • Development
  • Materials Science(all)

Cite this

Bharadwaj, G., Nhan, V., Yang, S. C., Li, X., Narayanan, A., MacArenco, A. C., ... Lam, K. (2017). Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes. Nanomedicine, 12(10), 1153-1164. https://doi.org/10.2217/nnm-2017-0361

Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes. / Bharadwaj, Gaurav; Nhan, Viet; Yang, Shan Chao; Li, Xiaocen; Narayanan, Anand; MacArenco, Ana Carolina; Shi, Yu; Yang, Darrion; Vieira, Letícia Salvador; Xiao, Wenwu; Li, Yuanpei; Lam, Kit.

In: Nanomedicine, Vol. 12, No. 10, 01.05.2017, p. 1153-1164.

Research output: Contribution to journalArticle

Bharadwaj, G, Nhan, V, Yang, SC, Li, X, Narayanan, A, MacArenco, AC, Shi, Y, Yang, D, Vieira, LS, Xiao, W, Li, Y & Lam, K 2017, 'Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes', Nanomedicine, vol. 12, no. 10, pp. 1153-1164. https://doi.org/10.2217/nnm-2017-0361
Bharadwaj G, Nhan V, Yang SC, Li X, Narayanan A, MacArenco AC et al. Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes. Nanomedicine. 2017 May 1;12(10):1153-1164. https://doi.org/10.2217/nnm-2017-0361
Bharadwaj, Gaurav ; Nhan, Viet ; Yang, Shan Chao ; Li, Xiaocen ; Narayanan, Anand ; MacArenco, Ana Carolina ; Shi, Yu ; Yang, Darrion ; Vieira, Letícia Salvador ; Xiao, Wenwu ; Li, Yuanpei ; Lam, Kit. / Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes. In: Nanomedicine. 2017 ; Vol. 12, No. 10. pp. 1153-1164.
@article{faf7b9dfbc494c26942a2668f51a51f0,
title = "Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes",
abstract = "Aim: To structurally modify our existing cholic acid (CA)-based telodendrimer (TD; PEG5K-CA8) for effective micellar nanoencapsulation and delivery of the US FDA-approved members of taxane family. Materials & methods: Generation of hybrid TDs was achieved by replacing four of the eight CAs with biocompatible organic moieties using solution-phase peptide synthesis. Drug loading was done using the standard evaporation method. Results: Hybrid TDs can generate micelles with narrow size distributions, low critical micelle concentration values (1-6 μM), better hematocompatibility and lack of in vitro cytotoxicity. Conclusion: Along with PEG5K-CA8, CA-based hybrid nanoplatform is the first of its kind that can stably encapsulate all three FDA-approved taxanes with nearly 100{\%} efficiency up to 20{\%} (w/w) loading.",
keywords = "cabazitaxel, cholic acid, docetaxel, drug delivery, micelle, nanoparticle, paclitaxel, taxane, telodendrimer",
author = "Gaurav Bharadwaj and Viet Nhan and Yang, {Shan Chao} and Xiaocen Li and Anand Narayanan and MacArenco, {Ana Carolina} and Yu Shi and Darrion Yang and Vieira, {Let{\'i}cia Salvador} and Wenwu Xiao and Yuanpei Li and Kit Lam",
year = "2017",
month = "5",
day = "1",
doi = "10.2217/nnm-2017-0361",
language = "English (US)",
volume = "12",
pages = "1153--1164",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine Ltd.",
number = "10",

}

TY - JOUR

T1 - Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes

AU - Bharadwaj, Gaurav

AU - Nhan, Viet

AU - Yang, Shan Chao

AU - Li, Xiaocen

AU - Narayanan, Anand

AU - MacArenco, Ana Carolina

AU - Shi, Yu

AU - Yang, Darrion

AU - Vieira, Letícia Salvador

AU - Xiao, Wenwu

AU - Li, Yuanpei

AU - Lam, Kit

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Aim: To structurally modify our existing cholic acid (CA)-based telodendrimer (TD; PEG5K-CA8) for effective micellar nanoencapsulation and delivery of the US FDA-approved members of taxane family. Materials & methods: Generation of hybrid TDs was achieved by replacing four of the eight CAs with biocompatible organic moieties using solution-phase peptide synthesis. Drug loading was done using the standard evaporation method. Results: Hybrid TDs can generate micelles with narrow size distributions, low critical micelle concentration values (1-6 μM), better hematocompatibility and lack of in vitro cytotoxicity. Conclusion: Along with PEG5K-CA8, CA-based hybrid nanoplatform is the first of its kind that can stably encapsulate all three FDA-approved taxanes with nearly 100% efficiency up to 20% (w/w) loading.

AB - Aim: To structurally modify our existing cholic acid (CA)-based telodendrimer (TD; PEG5K-CA8) for effective micellar nanoencapsulation and delivery of the US FDA-approved members of taxane family. Materials & methods: Generation of hybrid TDs was achieved by replacing four of the eight CAs with biocompatible organic moieties using solution-phase peptide synthesis. Drug loading was done using the standard evaporation method. Results: Hybrid TDs can generate micelles with narrow size distributions, low critical micelle concentration values (1-6 μM), better hematocompatibility and lack of in vitro cytotoxicity. Conclusion: Along with PEG5K-CA8, CA-based hybrid nanoplatform is the first of its kind that can stably encapsulate all three FDA-approved taxanes with nearly 100% efficiency up to 20% (w/w) loading.

KW - cabazitaxel

KW - cholic acid

KW - docetaxel

KW - drug delivery

KW - micelle

KW - nanoparticle

KW - paclitaxel

KW - taxane

KW - telodendrimer

UR - http://www.scopus.com/inward/record.url?scp=85019569566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019569566&partnerID=8YFLogxK

U2 - 10.2217/nnm-2017-0361

DO - 10.2217/nnm-2017-0361

M3 - Article

C2 - 28447909

AN - SCOPUS:85019569566

VL - 12

SP - 1153

EP - 1164

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 10

ER -